Therefore, it is possible that reduced BMP9 and pBMP10 levels represent a marker of decompensation in advanced liver disease, increasing the susceptibility to PoPH and HPS. The gene discussed is GDF2; the disease is Pulmonary arterial hypertension associated with portal hypertension.